Cytomx Therapeutics, Inc. · NASDAQ:CTMX

Longitude Capital Partners V, LLC reported a 7.30% stake in Cytomx Therapeutics, Inc. (Schedule 13G)

Event May 13, 2025 · Filed May 20, 2025

Longitude Capital Partners V, LLC reported a 7.30% stake in Cytomx Therapeutics, Inc., 11,538,461 shares, as a passive investor on May 13, 2025. Filed May 20, 2025 (Schedule 13G).

Stake
7.30%
Shares
11,538,461
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Longitude Capital Partners V, LLC7.30%11,538,461
Longitude Venture Partners V, L.P.7.30%11,538,461
Patrick G. Enright7.30%11,538,461
Juliet Tammenoms Bakker7.30%11,538,461

Source

View original at SEC

Related